Ceapro Announces Termination of Investor Relations Contract
EDMONTON, ALBERTA, CANADA -- (Marketwire) -- 10/02/12 -- Ceapro Inc. (TSX VENTURE: CZO) wishes to inform its shareholders that it has terminated its month to month contract with Renmark Financial Communications Inc. to provide investor relations services.
Questions regarding press releases can be forwarded to Branko Jankovic, the Chief Financial Officer.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides.
To learn more about Ceapro, visit www.ceapro.com.
The TSX Venture Exchange nor its Regulation Services Provide (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts: Branko Jankovic Chief Financial Officer Ceapro Inc. 780.917.8376 (Edmonton) email@example.com
Source: Ceapro Inc.
Released October 3, 2012